We're desperate for a coronavirus cure, but at what cost to the human guinea pigs? | Kenan Malik

Big drugs companies have long favoured outsourcing clinical trials to poor countries with lax regulations to cut costs and maximise profit

• Coronavirus latest updates

• See all our coronavirus coverage

Last week, in Oxford, the first volunteers in the first European human trial were injected with a potential coronavirus vaccine. At the same time, Pakistan’s National Institute of Health received an offer from the Chinese pharmaceutical firm Sinopharm International Corp to take part in a trial of another potential coronavirus vaccine.

Related: Africa's Covid-19 research must be tailored to its realities – by its own scientists | Monique Wasunna

Continue reading...

from The Guardian https://ift.tt/2yHGgME

Comments

Popular posts from this blog

‘Help us or LSO fails’: Sir Simon Rattle’s plea over Covid and Brexit

Mark Kermode’s best films of 2019

The Glasgow Effect: examining the city's life expectancy gap – a photo essay